Les mitochondries, chevilles ouvrières de la résistance aux traitements des leucémies aiguës myéloïdes. Nouveau biomarqueur et potentielle cible thérapeutique en vue !
@crctoncopole@jeansarry@Claudie_Bosc
https://t.co/so17wobuG9
We showed that 1- using an approach based on a "MitoScore" at diagnosis is crucial to choose the successful VEN-based treatment strategy for AML patients ; 2- mitochondrial adaptation is central in VEN+AraC resistance, supporting the design of mito-targeted strategies with VEN.
I am super excited to share our new paper and latest story coming out of my PhD thesis 🎉
Many thanks to my mentor Dr Jean-Emmanuel Sarry and all the lab for their great support throughout this project ! Also a big thanks to all our great collaborators !
⭐️ONLINE NOW @NatureCancer: Mitochondrial inhibitors circumvent adaptive #resistance to venetoclax and cytarabine combination #therapy in #AML, a fantastic work by @jeansarry &Co
Do not miss this one! Links below 👇
https://t.co/9n7GlGVCz9
https://t.co/USQejjMBGv
#leukemia
[RT appréciés] Dernier jour pour s'inscrire aux #JJC2020. Un événement ouvert à toute la communauté scientifique : venez écouter les Jeunes Chercheurs qui représentent l'avenir de la recherche sur le #cancer !
➡️Inscriptions : https://t.co/jUMcwDHR3E
Congrats to everyone implied, including our brand new PhD @BoscClaudie ;) Hard work paying off is always fantastic to watch <3 #autophagy#cancermetabolism